Legal status of recreational cannabis and self-reported substitution of cannabis for opioids or prescription pain medication in Canada and the United States

被引:9
作者
Wadsworth, Elle [1 ]
Hines, Lindsey A. [2 ,3 ]
Hammond, David [1 ]
机构
[1] Univ Waterloo, Sch Publ Hlth Sci, 200 Univ Ave W, Waterloo, ON N2L 3G1, Canada
[2] Univ Bristol, Bristol Med Sch, Populat Hlth Sci, Bristol, Avon, England
[3] Univ Bristol, Bristol Med Sch, Integrat Epidemiol Unit, Bristol, Avon, England
基金
英国惠康基金; 加拿大健康研究院;
关键词
Opioids; pain; cannabis; marijuana; legalization; substitution; MARIJUANA; LEGALIZATION; DEATHS; LAWS;
D O I
10.1080/08897077.2022.2060431
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Aims: With increased liberalization of cannabis policies in North America, there is growing interest in the use of cannabis to manage pain instead of opioids. The objectives of the study were to (1) examine the use of cannabis for pain relief in Canada and the United States (US) in 2018 and 2019; (2) examine the association between recreational cannabis laws and changes in the use of cannabis for pain relief, instead of opioids or prescription pain medication. Methods: Repeat cross-sectional survey data were used from Wave 1 and Wave 2 of the International Cannabis Policy Study conducted in 2018 and 2019 in Canada and the US. Respondents were recruited through commercial panels, aged 16-65, and had ever tried cannabis (N = 44,119). Weighted binary logistic regression models examined the association between the legal status of recreational cannabis and cannabis use for pain relief instead of opioids or prescription pain medication (n = 15,092). Results: Between 14-33% of cannabis consumers in Canada and the US reported using cannabis to manage headaches or pain. Of these consumers, 79% and 78% respondents in Canada; 80% and 83% in US illegal states; and 83% and 84% in US legal states, in 2018 and 2019, respectively, reported cannabis use for pain relief instead of opioids or prescription pain medication. There was little evidence of an association between the legal status of recreational cannabis and cannabis use for pain relief instead of opioids or prescription pain medication, among Canadian (AOR = 0.98, 95% CI: 0.78, 1.22) and US respondents (AOR = 1.11, 95% CI: 0.96, 1.28). Conclusions: Although substitution of cannabis for opioids or prescription pain medication is common among those who use cannabis for pain, there does not seem to be a significant difference according to cannabis legality. Future research should examine cannabis and opioid substitution using different research designs and time frames.
引用
收藏
页码:943 / 948
页数:6
相关论文
共 31 条
  • [1] Medical Cannabis Laws and Opioid Analgesic Overdose Mortality in the United States, 1999-2010
    Bachhuber, Marcus A.
    Saloner, Brendan
    Cunningham, Chinazo O.
    Barry, Colleen L.
    [J]. JAMA INTERNAL MEDICINE, 2014, 174 (10) : 1668 - 1673
  • [2] Becker WC., 2021, AIDS CARE, V34, P1
  • [3] Association Between US State Medical Cannabis Laws and Opioid Prescribing in the Medicare Part D Population
    Bradford, Ashley C.
    Bradford, W. David
    Abraham, Amanda
    Adams, Grace Bagwell
    [J]. JAMA INTERNAL MEDICINE, 2018, 178 (05) : 667 - 672
  • [4] THE EFFECTS OF RECREATIONAL MARIJUANA LEGALIZATION AND DISPENSING ON OPIOID MORTALITY
    Chan, Nathan W.
    Burkhardt, Jesse
    Flyr, Matthew
    [J]. ECONOMIC INQUIRY, 2020, 58 (02) : 589 - 606
  • [5] State marijuana laws and opioid overdose mortality
    Chihuri, Stanford
    Li, Guohua
    [J]. INJURY EPIDEMIOLOGY, 2019, 6 (01)
  • [6] Cannabis as a substitute for prescription drugs - a cross-sectional study
    Corroon, James M., Jr.
    Mischley, Laurie K.
    Sexton, Michelle
    [J]. JOURNAL OF PAIN RESEARCH, 2017, 10 : 989 - 997
  • [7] A Description of the Medical Cannabis Use in Ontario, Canada
    Eurich, Dean T.
    Hanlon, John G.
    Boisvenue, Jamie J.
    Meng, Howard
    Dyck, Jason R. B.
    [J]. CANNABIS AND CANNABINOID RESEARCH, 2019, 4 (02) : 131 - 135
  • [8] Goodman S, 2020, INT CANNABIS POLICY
  • [9] Is Cannabis being used as a substitute for non-medical opioids by adults with problem substance use in the United States? A within-person analysis
    Gorfinkel, Lauren R.
    Stohl, Malki
    Greenstein, Eliana
    Aharonovich, Efrat
    Olfson, Mark
    Hasin, Deborah
    [J]. ADDICTION, 2021, 116 (05) : 1113 - 1121
  • [10] Evaluating the public health impacts of legalizing recreational cannabis use in the United States
    Hall, Wayne
    Lynskey, Michael
    [J]. ADDICTION, 2016, 111 (10) : 1764 - 1773